214 related articles for article (PubMed ID: 16669270)
1. [More modest use in secondary prevention, risky in primary prevention].
MMW Fortschr Med; 2006 Apr; 148(14):10-1. PubMed ID: 16669270
[No Abstract] [Full Text] [Related]
2. [New guidelines in acute coronary syndrome. Clopidogrel for nine months is recommended].
MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440296
[No Abstract] [Full Text] [Related]
3. [Secondary prevention of TIA and stroke. How much must thrombocytes not be inhibited?].
Einecke D
MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366495
[No Abstract] [Full Text] [Related]
4. Plavix isn't for everyone. Adding Plavix to aspirin doesn't help people without heart disease.
Harv Heart Lett; 2006 Jun; 16(10):1. PubMed ID: 16791939
[No Abstract] [Full Text] [Related]
5. Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE.
Mehta SR
J Invasive Cardiol; 2003 Mar; 15 Suppl B():17B-20B; discussion 20B-21B. PubMed ID: 12724582
[No Abstract] [Full Text] [Related]
6. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
7. [ASA or clopidogrel?].
Janzon L
Lakartidningen; 2000 May; 97(22):2775-6. PubMed ID: 10900900
[No Abstract] [Full Text] [Related]
8. Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.
Cardiovasc J Afr; 2009; 20(3):205. PubMed ID: 19575092
[No Abstract] [Full Text] [Related]
9. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
Wang TH; Bhatt DL; Fox KA; Steinhubl SR; Brennan DM; Hacke W; Mak KH; Pearson TA; Boden WE; Steg PG; Flather MD; Montalescot G; Topol EJ;
Eur Heart J; 2007 Sep; 28(18):2200-7. PubMed ID: 17673448
[TBL] [Abstract][Full Text] [Related]
10. [For which patient ASS, clopidogrel or dipyridamole? (interview by Dr. Med. Dirk Einecke)].
Diener HC
MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366496
[No Abstract] [Full Text] [Related]
11. [Acute heart attacks. Prognosis can be further improved].
Einecke D
MMW Fortschr Med; 2001 Apr; 143(14):4-5. PubMed ID: 11340908
[No Abstract] [Full Text] [Related]
12. [Clopidogrel as basic therapy in high-risk stroke patients].
Mattle HP
Praxis (Bern 1994); 2004 Aug; 93(34):1364. PubMed ID: 15468694
[No Abstract] [Full Text] [Related]
13. [Clopidogrel and aspirin versus aspirin alone in prevention of atherothrombotic events. The results of CHARISMA study].
Gaciong Z
Kardiol Pol; 2006 May; 64(5):548-51; discussion 551-2. PubMed ID: 16752345
[No Abstract] [Full Text] [Related]
14. [Prevention of atherothrombotic incidents. CHARISMA Study (The Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance].
Erdmann E
Internist (Berl); 2006 Dec; 47(12):1295-7. PubMed ID: 17096154
[No Abstract] [Full Text] [Related]
15. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
[No Abstract] [Full Text] [Related]
16. Clopidogrel: new indication. In combination with aspirin: marginal additional benefits.
Prescrire Int; 2007 Aug; 16(90):146. PubMed ID: 17724837
[TBL] [Abstract][Full Text] [Related]
17. Safer heart-attack prevention for seniors with revised drug regimen. Half the normal dose of prasugrel, a lifesaving medication, is just as effective as the larger dose, and reduces risk of serious side effects.
Duke Med Health News; 2013 Nov; 19(11):1-2. PubMed ID: 24611195
[No Abstract] [Full Text] [Related]
18. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
19. [After the heart catheter. 2 thrombocyte inhibitors for a whole year?].
Silber S
MMW Fortschr Med; 2003 Jan; 145(3-4):16. PubMed ID: 12619228
[No Abstract] [Full Text] [Related]
20. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
MMW Fortschr Med; 2008 Oct; 150(42):52-3. PubMed ID: 18983063
[No Abstract] [Full Text] [Related]
[Next] [New Search]
